South Korean telecommunication giant KT Corporation has partnered with health tech company HurayPositive to develop and launch a telemedicine service for managing chronic diseases in Vietnam.
According to a press statement, the telemedicine platform is targeted to be launched within the year and will start by offering virtual services for diabetic patients before gradually offering support for...
Taiwanese chronic disease management company Health2Sync has entered into a partnership with Danish pharmaceutical firm Novo Nordisk to help patients undergoing insulin therapy wirelessly transfer dose logs to a mobile health app.
The Health2Sync mobile app is now able to sync patients' dose logs, including time and dosage per injection, from the newly released NovoPen 6 and NovoPen Echo Plus...
HeartVoice, a health tech startup in Singapore, has acquired Integrated Wellness Clinic in Novena Specialist Centre and formed a new entity offering preventive healthcare solutions.
A joint venture between Japanese medical device maker OMRON Healthcare and Singapore-based financial medical technology firm iAPPS Health Group, HeartVoice offers a range of medical technology solutions for healthcare...
Queensland-based digital health firm Cardihab and Baker Heart and Diabetes Institute, a medical research organisation in Melbourne, have signed a five-year agreement to jointly conduct clinical trials and cohort studies to deliver evidence of the effectiveness of digital approaches to cardiovascular disease management, rehabilitation, prevention and treatment.
The research programme will see wide...
India-based digital chronic disease management platform BeatO has raised $5.7 million in a funding round led by W Health Ventures, an American venture capital firm. The investing round was also participated by Threpsi Solutions' e-pharmacy unicorn PharmEasy, Merisis VP and previous investors.
The digital health startup has raked in over $10 million in investor funds since last year.
WHAT IT DOES...
Stockholm-based digital health company NuvoAir has raised $12 million (€10M) to expand its chronic disease management and clinical trial platforms.
The Series A funding round was led by AlbionVC and comes off the back of a record 500% growth for NuvoAir in the first quarter of 2021.
KAYA (formerly Enern), Amino Collective and existing shareholders Spiltan, Industrifonden and Novartis Pharma AG (...
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health Catalyst Capital. Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic also played a part in the raise.
WHAT IT DOES
The Palo Alto startup's app-based platform acts as a central hub for connected monitoring devices and other...
In December, Highmark Health announced a six-year collaboration with Google Cloud that the companies said would lay down the infrastructure of the integrated delivery network's data-driven Living Health Dynamic Platform.
Today, the organizations unveiled plans to get Verily and its Onduo chronic care subsidiary in on the action as well. Through another six-year partnership, the partners will work...
DarioHealth announced today that it is expanding its digital chronic-disease-management business beyond diabetes and hypertension with the purchase of Upright Technologies, a musculoskeletal (MSK) health company that specializes in connected posture correction devices and digital coaching.
The deal is expected to close on or around February 7, and will run DarioHealth $31 million to complete the...
Today One Drop announced a string of new deals with Bayer that could bring the digital diabetes-management company nearly $100 million in new funds.
The agreements include the closure of a Series C financing round led by the pharma giant, as well as $64 million in unspecified development commitments and potential commercial milestone payments.
Launched in late 2016, One Drop's wireless blood...